Literature DB >> 34081357

Sex differences in systemic bone and muscle loss following femur fracture in mice.

Benjamin Osipov1, Manali P Paralkar1, Armaun J Emami1, Hailey C Cunningham1, Priscilla M Tjandra1, Suraj Pathak2, Henning T Langer3, Keith Baar2,3, Blaine A Christiansen1.   

Abstract

Fracture induces systemic bone loss in mice and humans, and a first (index) fracture increases the risk of future fracture at any skeletal site more in men than women. The etiology of this sex difference is unknown, but fracture may induces a greater systemic bone loss response in men. Also sex differences in systemic muscle loss after fracture have not been examined. We investigated sex differences in systemic bone and muscle loss after transverse femur fracture in 3-month-old male and female C57BL/6 J mice. Whole-body and regional bone mineral content and density (BMC and BMD), trabecular and cortical bone microstructure, muscle contractile force, muscle mass, and muscle fiber size were quantified at multiple time points postfracture. Serum concentrations of inflammatory cytokines (IL-1β, IL-6, and TNF-α) were measured 1-day postfracture. One day postfracture, IL-6 and Il-1B were elevated in fracture mice of both sexes, but TNF-α was only elevated in male fracture mice. Fracture reduced BMC, BMD, and trabecular bone microstructural properties in both sexes 2 weeks postfracture, but declines were greater in males. Muscle contractile force, mass, and fiber size decreased primarily in the fractured limb at 2 weeks postfracture and females showed a trend toward greater muscle loss. Bone and muscle properties recovered by 6 weeks postfracture. Overall, postfracture systemic bone loss is greater in men, which may contribute to sex differences in subsequent fracture risk. In both sexes, muscle loss is primarily confined to the injured limb and fracture may induce greater inflammation in males.
© 2021 Orthopaedic Research Society. Published by Wiley Periodicals LLC.

Entities:  

Keywords:  fracture; muscle; sex; systemic bone loss

Mesh:

Substances:

Year:  2021        PMID: 34081357      PMCID: PMC8639826          DOI: 10.1002/jor.25116

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  49 in total

Review 1.  Estrogen and the skeleton.

Authors:  Sundeep Khosla; Merry Jo Oursler; David G Monroe
Journal:  Trends Endocrinol Metab       Date:  2012-05-16       Impact factor: 12.015

2.  Patterns of cytokine release and evolution of remote organ dysfunction after bilateral femur fracture.

Authors:  Philipp Kobbe; Yoram Vodovotz; David J Kaczorowski; Kevin P Mollen; Timothy R Billiar; Hans-Christoph Pape
Journal:  Shock       Date:  2008-07       Impact factor: 3.454

Review 3.  Osteoporosis in older men: recent advances in pathophysiology and treatment.

Authors:  Michaël Laurent; Evelien Gielen; Frank Claessens; Steven Boonen; Dirk Vanderschueren
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-05-23       Impact factor: 4.690

Review 4.  Update on osteoporosis in men.

Authors:  Robert A Adler
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-05-26       Impact factor: 4.690

Review 5.  The Role of TGFβ in Bone-Muscle Crosstalk.

Authors:  Jenna N Regan; Trupti Trivedi; Theresa A Guise; David L Waning
Journal:  Curr Osteoporos Rep       Date:  2017-02       Impact factor: 5.096

6.  Gender differences in human sepsis.

Authors:  J Schröder; V Kahlke; K H Staubach; P Zabel; F Stüber
Journal:  Arch Surg       Date:  1998-11

7.  Estrogen replacement, aging, and cell-mediated immunity after injury.

Authors:  Elizabeth J Kovacs; Timothy P Plackett; Pamela L Witte
Journal:  J Leukoc Biol       Date:  2004-02-03       Impact factor: 4.962

Review 8.  Pathogenesis of age-related bone loss in humans.

Authors:  Sundeep Khosla
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-08-24       Impact factor: 6.053

9.  Production of a standard closed fracture in laboratory animal bone.

Authors:  F Bonnarens; T A Einhorn
Journal:  J Orthop Res       Date:  1984       Impact factor: 3.494

10.  Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell cultures.

Authors:  Emily M Schmidt; Marie Davies; Prafull Mistry; Patricia Green; Grey Giddins; Marc Feldmann; A Allart Stoop; Fionula M Brennan
Journal:  Arthritis Rheum       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.